300 related articles for article (PubMed ID: 1730513)
1. A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.
Ye JN; Cheung NK
Int J Cancer; 1992 Jan; 50(2):197-201. PubMed ID: 1730513
[TBL] [Abstract][Full Text] [Related]
2. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.
Cheung NK; Canete A; Cheung IY; Ye JN; Liu C
Int J Cancer; 1993 May; 54(3):499-505. PubMed ID: 8509225
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.
Saito M; Yu RK; Cheung NK
Biochem Biophys Res Commun; 1985 Feb; 127(1):1-7. PubMed ID: 2579648
[TBL] [Abstract][Full Text] [Related]
4. Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells.
Sjoberg ER; Manzi AE; Khoo KH; Dell A; Varki A
J Biol Chem; 1992 Aug; 267(23):16200-11. PubMed ID: 1644805
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
Hamilton WB; Helling F; Lloyd KO; Livingston PO
Int J Cancer; 1993 Feb; 53(4):566-73. PubMed ID: 8436430
[TBL] [Abstract][Full Text] [Related]
6. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
Nishio M; Furukawa K
Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
[TBL] [Abstract][Full Text] [Related]
7. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T
Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889
[TBL] [Abstract][Full Text] [Related]
8. New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells.
Gross N; Beck D; Portoukalian J; Favre S; Carrel S
Int J Cancer; 1989 Apr; 43(4):665-71. PubMed ID: 2467885
[TBL] [Abstract][Full Text] [Related]
9. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
Tai T; Kawashima I; Tada N; Dairiki K
J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507
[TBL] [Abstract][Full Text] [Related]
10. Different reactivities of monoclonal antibodies to ganglioside lactones.
Tai T; Kawashima I; Tada N; Ikegami S
Biochim Biophys Acta; 1988 Jan; 958(1):134-8. PubMed ID: 3334863
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
Cheung NK; Cheung IY; Canete A; Yeh SJ; Kushner B; Bonilla MA; Heller G; Larson SM
Cancer Res; 1994 Apr; 54(8):2228-33. PubMed ID: 8174131
[TBL] [Abstract][Full Text] [Related]
13. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
Kawashima I; Tada N; Fujimori T; Tai T
J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
[TBL] [Abstract][Full Text] [Related]
15. Binding of monoclonal antibody A2B5 to gangliosides.
Kundu SK; Pleatman MA; Redwine WA; Boyd AE; Marcus DM
Biochem Biophys Res Commun; 1983 Nov; 116(3):836-42. PubMed ID: 6651849
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats.
Bergman I; Pohl CR; Venkataramanan R; Burckart GJ; Stabin M; Barmada MA; Griffin JA; Cheung NK
J Immunother; 1999 Mar; 22(2):114-23. PubMed ID: 10093036
[TBL] [Abstract][Full Text] [Related]
18. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
Cheresh DA; Pierschbacher MD; Herzig MA; Mujoo K
J Cell Biol; 1986 Mar; 102(3):688-96. PubMed ID: 3005335
[TBL] [Abstract][Full Text] [Related]
19. Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.
Cheung NK; Neely JE; Landmeier B; Nelson D; Miraldi F
J Nucl Med; 1987 Oct; 28(10):1577-83. PubMed ID: 3655911
[TBL] [Abstract][Full Text] [Related]
20. Targeting
Fleurence J; Fougeray S; Bahri M; Cochonneau D; Clémenceau B; Paris F; Heczey A; Birklé S
J Immunol Res; 2017; 2017():5604891. PubMed ID: 28154831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]